This information is for Healthcare Professionals only.
These promotional videos were organised and funded by Bristol Myers Squibb. BMS medicines and/or production information may be discussed.
Click here for Prescribing Information.
Symposium – Clinical Perspectives in UC: A Closer Look at S1P Receptor Modulators
Clinical Perspectives in UC: A Closer Look at S1P Receptor Modulators highlights the complexity of the current treatment landscape in managing patients progressing to moderate-to-severe UC, and introduces S1P receptor modulators in UC: an oral targeted therapy class.
Severine Vermeire reviews the current challenges faced among the UC clinical community and how the evolution of advanced therapies has shifted considerations in managing moderate-to-severe UC.
Bram Verstokt introduces the role of S1P modulators in UC, and Remo Panaccione reviews the clinical profile of approved and investigational S1P receptor modulator therapies.
Symposium: IBD Nurses at the Frontline of UC Care
IBD Nurses at the Frontline of UC Care highlights the challenges for patients with moderate-to-severe UC, the role of S1P modulators in UC, and how IBD nurses can impact care.
Jordan Axelrad reviews the current management of UC and the mechanism and clinical profile of S1P receptor modulators.
Revital Berkan and Petra Hartmann discuss the role of an IBD nurse in the era of targeted therapies and share practical experience of treating patients with S1P receptor modulators.
IMM-GB-2300387 | Date of Prep: October 2023
Adverse events should be reported. Reporting forms and information can be found via: Great Britain & Northern Ireland – The Yellow Card Scheme at: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Goggle Play or Apple App store; Ireland – HPRA Pharmacovigilance at www.hpra.ie. Adverse events should also be reported to Bristol-Myers Squibb via [email protected] or 08007311736 (Great Britain & Northern Ireland); 1 800 749 749 (Ireland).
